2466 Federal Register / Vol. 86, No. 7 / Tuesday, January 12, 2021 / Notices 

for Docket ID NRC–2020–0221. A copy 

of the collection of information and 

related instructions may be obtained 

without charge by accessing Docket ID 

NRC–2020–0221 on this website. 

• NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publicly 

available documents online in the 

ADAMS Public Documents collection at 

https://www.nrc.gov/reading-rm/ 

adams.html. To begin the search, select 

‘‘Begin Web-based ADAMS Search.’’ For 

problems with ADAMS, please contact 

the NRC’s Public Document Room (PDR) 

reference staff at 1–800–397–4209, 301– 

415–4737, or by email to pdr.resource@

nrc.gov. A copy of the collection of 

information and related instructions 

may be obtained without charge by 

accessing ADAMS Accession No. 

ML20205L413. The supporting 

statement is available in ADAMS under 

Accession No. ML20335A465. 

• Attention: The PDR, where you may 

examine and order copies of public 

documents is currently closed. You may 

submit your request to the PDR via 

email at pdr.resource@nrc.gov or call 1– 

800–397–4209 or 301–415–4737, 

between 8:00 a.m. and 4:00 p.m. (EST), 

Monday through Friday, except Federal 

holidays. 

• NRC’s Clearance Officer: A copy of 

the collection of information and related 

instructions may be obtained without 

charge by contacting the NRC’s 

Clearance Officer, David Cullison, 

Office of the Chief Information Officer, 

U.S. Nuclear Regulatory Commission, 

Washington, DC 20555–0001; telephone: 

301–415–2084; email: 

Infocollects.Resource@nrc.gov. 

B. Submitting Comments 

The NRC encourages electronic 

comment submission through the 

Federal Rulemaking website (https://

www.regulations.gov). Please include 

Docket ID NRC–2020–0221 in your 

comment submission. 

The NRC cautions you not to include 

identifying or contact information that 

you do not want to be publicly 

disclosed in your comment submission. 

The NRC will post all comment 

submissions at https://

www.regulations.gov as well as enter the 

comment submissions into ADAMS. 

The NRC does not routinely edit 

comment submissions to remove 

identifying or contact information. 

If you are requesting or aggregating 

comments from other persons for 

submission to the OMB, then you 

should inform those persons not to 

include identifying or contact 

information that they do not want to be 

publicly disclosed in their comment 

submission. Your request should state 

that comment submissions are not 

routinely edited to remove such 

information before making the comment 

submissions available to the public or 

entering the comment into ADAMS. 

II. Background 

Under the provisions of the 

Paperwork Reduction Act of 1995 (44 

U.S.C. Chapter 35), the NRC recently 

submitted a request for renewal of an 

existing collection of information to 

OMB for review entitled, NRC Form 

483, ‘‘Registration Certificate—In Vitro 

Testing with Byproduct Material Under 

General License.’’ The NRC hereby 

informs potential respondents that an 

agency may not conduct or sponsor, and 

that a person is not required to respond 

to, a collection of information unless it 

displays a currently valid OMB control 

number. 

The NRC published a Federal 

Register notice with a 60-day comment 

period on this information collection on 

October 8, 2020 (85 FR 63591). 

1. The title of the information 

collection: NRC Form 483, ‘‘Registration 

Certificate—In Vitro Testing with 

Byproduct Material Under General 

License.’’ 

2. OMB approval number: 3150–0038. 

3. Type of submission: Extension. 

4. The form number if applicable: 

NRC Form 483. 

5. How often the collection is required 

or requested: There is a one-time 

submittal of information to receive a 

validated copy of the NRC Form 483 

with an assigned registration number. In 

addition, any changes in the 

information reported on the NRC Form 

483 must be reported in writing to the 

NRC within 30 days after the effective 

date of the change. 

6. Who will be required or asked to 

respond: Any physician, veterinarian in 

the practice of veterinary medicine, 

clinical laboratory, or hospital which 

desires a general license to receive, 

acquire, possess, transfer, or use 

specified units of byproduct material in 

certain in vitro clinical or laboratory 

tests. 

7. The estimated number of annual 

responses: 6 responses. 

8. The estimated number of annual 

respondents: 6 respondents. 

9. An estimate of the total number of 

hours needed annually to comply with 

the information collection requirement 

or request: 1.12 hours. 

10. Abstract: Section 31.11 of title 10 

of the Code of Federal Regulations (10 

CFR), established a general license 

authorizing any physician, clinical 

laboratory, veterinarian in the practice 

of veterinary medicine, or hospital to 

possess certain small quantities of 

byproduct material for in vitro clinical 

or laboratory tests not involving the 

internal or external administration of 

the byproduct material or the radiation 

therefrom to human beings or animals. 

Possession of byproduct material under 

10 CFR 31.11 is not authorized until the 

physician, clinical laboratory, 

veterinarian in the practice of veterinary 

medicine, or hospital has filed the NRC 

Form 483 and received from the 

Commission a validated copy of the 

NRC Form 483 with a registration 

number. The licensee can use the 

validated copy of the NRC Form 483 to 

obtain byproduct material from a 

specifically licensed supplier. The NRC 

incorporates this information into a 

database which is used to verify that a 

general licensee is authorized to receive 

the byproduct material. 

Dated: January 6, 2021. 

For the Nuclear Regulatory Commission. 

David C. Cullison, 

NRC Clearance Officer, Office of the Chief 

Information Officer. 

[FR Doc. 2021–00331 Filed 1–11–21; 8:45 am] 

BILLING CODE 7590–01–P 

SECURITIES AND EXCHANGE 

COMMISSION 

[Investment Company Act Release No. 

34165; File No. 812–15066] 

Symmetry Panoramic Trust and 

Symmetry Partners, LLC 

January 6, 2021. 

AGENCY: Securities and Exchange 

Commission (‘‘Commission’’). 

ACTION: Notice. 

Notice of an application for an order 

pursuant to: (a) Section 6(c) of the 

Investment Company Act of 1940 

(‘‘Act’’) granting an exemption from 

sections 18(f) and 21(b) of the Act; (b) 

section 12(d)(1)(J) of the Act granting an 

exemption from section 12(d)(1) of the 

Act; (c) sections 6(c) and 17(b) of the 

Act granting an exemption from sections 

17(a)(1), 17(a)(2) and 17(a)(3) of the Act; 

and (d) section 17(d) of the Act and rule 

17d–1 under the Act to permit certain 

joint arrangements and transactions. 

Applicants request an order that would 

permit certain registered management 

investment companies to participate in 

a joint lending and borrowing facility. 

Applicants: Symmetry Panoramic 

Trust, a Delaware statutory trust 

registered under the Act as an open-end 

management investment company with 

multiple series, and Symmetry Partners, 

LLC (‘‘Symmetry Partners’’), a 

Connecticut limited liability company 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 7 / Tuesday, January 12, 2021 / Notices 2467 

1Applicants request that the order apply to the 

Applicants and to any registered open-end 

management investment company or series thereof 

for which Symmetry Partners or any successor 

thereto, or an investment adviser controlling, 

controlled by, or under common control with 

Symmetry Partners or any successor thereto, serves 

as investment adviser (each such investment 

company or series thereof, a ‘‘Fund’’ and 

collectively the ‘‘Funds,’’ and each such investment 

adviser, an ‘‘Adviser’’). For purposes of the 

requested order, ‘‘successor’’ is limited to any entity 

that results from a reorganization into another 

jurisdiction or a change in the type of a business 

organization. 

2Any Fund, however, will be able to call a loan 

on one business day’s notice. 

3Under certain circumstances, a borrowing Fund 

will be required to pledge collateral to secure the 

loan. 

4Applicants state that the obligation to repay an 

interfund loan could be deemed to constitute a 

security for the purposes of sections 17(a)(1) and 

12(d)(1) of the Act. 

5Applicants state that any pledge of securities to 

secure an interfund loan could constitute a 

purchase of securities for purposes of section 

17(a)(2) of the Act. 

that is registered as an investment 

adviser under the Investment Advisers 

Act of 1940. 

Filing Dates: The application was 

filed on September 4, 2019, and 

amended on May 28, 2020, September 4, 

2020, and December 18, 2020. 

Hearing or Notification of Hearing: An 

order granting the requested relief will 

be issued unless the Commission orders 

a hearing. Interested persons may 

request a hearing by emailing the 

Commission’s Secretary at SecretarysOffice@sec.gov and serving Applicants 

with a copy of the request by email. 

Hearing requests should be received by 

the Commission by 5:30 p.m. on 

February 1, 2021, and should be 

accompanied by proof of service on 

Applicants, in the form of an affidavit, 

or, for lawyers, a certificate of service. 

Pursuant to Rule 0–5 under the Act, 

hearing requests should state the nature 

of the writer’s interest, any facts bearing 

upon the desirability of a hearing on the 

matter, the reason for the request, and 

the issues contested. Persons who wish 

to be notified of a hearing may request 

notification by emailing the 

Commission’s Secretary at SecretarysOffice@sec.gov. 

ADDRESSES: The Commission: 

Secretarys-Office@sec.gov. Applicants: 

Mark C. Amorosi, Esq., mark.amorosi@

klgates.com (with a copy to Philip R. 

McDonald, pmcdonald@

SymmetryPartners.com). 

FOR FURTHER INFORMATION CONTACT: 

Laura J. Riegel, Senior Counsel, or Trace 

W. Rakestraw, Branch Chief, at (202) 

551–6825 (Division of Investment 

Management, Chief Counsel’s Office). 

SUPPLEMENTARY INFORMATION: The 

following is a summary of the 

application. The complete application 

may be obtained via the Commission’s 

website by searching for the file 

number, or an applicant using the 

Company name box, at http://

www.sec.gov/search/search.htm or by 

calling (202) 551–8090. 

Summary of the Application: 

1. Applicants request an order that 

would permit the Applicants to 

participate in an interfund lending 

facility where each Fund could lend 

money directly to and borrow money 

directly from other Funds to cover 

unanticipated cash shortfalls, such as 

unanticipated redemptions or sales 

fails.1 The Funds will not borrow under 

the facility for leverage purposes and 

the loans’ duration will be no more than 

7 days.2

2. Applicants anticipate that the 

proposed facility would provide a 

borrowing Fund with a source of 

liquidity at a rate lower than the bank 

borrowing rate at times when the cash 

position of the Fund is insufficient to 

meet temporary cash requirements. In 

addition, Funds making short-term cash 

loans directly to other Funds would 

earn interest at a rate higher than they 

otherwise could obtain from investing 

their cash in repurchase agreements or 

certain other short term money market 

instruments. Thus, Applicants assert 

that the facility would benefit both 

borrowing and lending Funds. 

3. Applicants agree that any order 

granting the requested relief will be 

subject to the terms and conditions 

stated in the application. Among others, 

the Adviser, through a designated 

committee, would administer the 

facility as a disinterested fiduciary as 

part of its duties under the investment 

advisory and administrative services 

agreements with the Funds and would 

receive no additional fee as 

compensation for its services in 

connection with the administration of 

the facility. The facility would be 

subject to oversight and certain 

approvals by the Funds’ Board, 

including, among others, approval of the 

interest rate formula and of the method 

for allocating loans across Funds, as 

well as review of the process in place to 

evaluate the liquidity implications for 

the Funds. A Fund’s aggregate 

outstanding interfund loans will not 

exceed 15% of its net assets at the time 

of the loan, and the Fund’s loans to any 

one Fund will not exceed 5% of the 

lending Fund’s net assets.3

4. Applicants assert that the facility 

does not raise the concerns underlying 

section 12(d)(1) of the Act given that the 

Funds are part of the same group of 

investment companies and there will be 

no duplicative costs or fees to the 

Funds.4 Applicants also assert that the 

proposed transactions do not raise the 

concerns underlying sections 17(a)(1), 

17(a)(3), 17(d) and 21(b) of the Act as 

the Funds would not engage in lending 

transactions that unfairly benefit 

insiders or are detrimental to the Funds. 

Applicants state that the facility will 

offer both reduced borrowing costs and 

enhanced returns on loaned funds to all 

participating Funds and each Fund 

would have an equal opportunity to 

borrow and lend on equal terms based 

on an interest rate formula that is 

objective and verifiable. With respect to 

the relief from section 17(a)(2) of the 

Act, Applicants note that any collateral 

pledged to secure an interfund loan 

would be subject to the same conditions 

imposed by any other lender to a Fund 

that imposes conditions on the quality 

of or access to collateral for a borrowing 

(if the lender is another Fund) or the 

same or better conditions (in any other 

circumstance).5

5. Applicants also believe that the 

limited relief from section 18(f)(1) of the 

Act that is necessary to implement the 

facility (because the lending Funds are 

not banks) is appropriate in light of the 

conditions and safeguards described in 

the application and because the Funds 

would remain subject to the 

requirement of section 18(f)(1) that all 

borrowings of the Fund, including 

combined interfund loans and bank 

borrowings, have at least 300% asset 

coverage. 

6. Section 6(c) of the Act permits the 

Commission to exempt any persons or 

transactions from any provision of the 

Act if such exemption is necessary or 

appropriate in the public interest and 

consistent with the protection of 

investors and the purposes fairly 

intended by the policy and provisions of 

the Act. Section 12(d)(1)(J) of the Act 

provides that the Commission may 

exempt any person, security, or 

transaction, or any class or classes of 

persons, securities, or transactions, from 

any provision of section 12(d)(1) if the 

exemption is consistent with the public 

interest and the protection of investors. 

Section 17(b) of the Act authorizes the 

Commission to grant an order 

permitting a transaction otherwise 

prohibited by section 17(a) if it finds 

that (a) the terms of the proposed 

transaction, including the compensation 

to be paid or received, are fair and 

reasonable and do not involve 

overreaching on the part of any person 

concerned; (b) the proposed transaction 

is consistent with the policies of each 


khammond on DSKJM1Z7X2PROD with NOTICES
2468 Federal Register / Vol. 86, No. 7 / Tuesday, January 12, 2021 / Notices 

1 15 U.S.C. 78s(b)(1). 

2 17 CFR 240.19b–4. 

3 15 U.S.C. 78s(b)(3)(A). 

4 17 CFR 240.19b–4(f)(2). 

5All capitalized terms not defined herein have 

the same definition as the CDSClearing Rule Book, 

Supplement or Procedures, as applicable. 

registered investment company 

involved; and (c) the proposed 

transaction is consistent with the 

general purposes of the Act. Rule 17d– 

1(b) under the Act provides that in 

passing upon an application filed under 

the rule, the Commission will consider 

whether the participation of the 

registered investment company in a 

joint enterprise, joint arrangement or 

profit sharing plan on the basis 

proposed is consistent with the 

provisions, policies and purposes of the 

Act and the extent to which such 

participation is on a basis different from 

or less advantageous than that of the 

other participants. 

For the Commission, by the Division of 

Investment Management, under delegated 

authority. 

J. Matthew DeLesDernier, 

Assistant Secretary. 

[FR Doc. 2021–00330 Filed 1–11–21; 8:45 am] 

BILLING CODE 8011–01–P 

SECURITIES AND EXCHANGE 

COMMISSION 

[Release No. 34–90862; File No. SR–LCH 

SA–2020–007] 

Self-Regulatory Organizations; LCH 

SA; Notice of Filing and Immediate 

Effectiveness of Proposed Rule 

Change Relating to the Amendments 

of the CDSClear Fee Grid 

January 6, 2021. 

Pursuant to Section 19(b)(1) of the 

Securities Exchange Act of 1934 

(‘‘Act’’) 1 and Rule 19b–4 thereunder 2

notice is hereby given that on December 

31, 2020, Banque Centrale de 

Compensation, which conducts 

business under the name LCH SA (‘‘LCH 

SA’’), filed with the Securities and 

Exchange Commission (‘‘Commission’’) 

the proposed rule change described in 

Items I, II, and III below, which Items 

have been prepared by LCH SA. LCH SA 

filed the proposed rule change pursuant 

to Section 19(b)(3)(A) of the Act,3 and 

Rule 19b–4(f)(2) 4 thereunder, so that the 

proposed rule change was effective 

upon filing with the Commission. The 

Commission is publishing this notice to 

solicit comments on the proposed rule 

change from interested persons. 

I. Clearing Agency’s Statement of the 

Terms of Substance of the Proposed 

Rule Change 

The proposed rule change is to review 

and modify the current CDSClear fee 

grid applied by LCH SA. 

The text of the proposed rule change 

has been annexed as Exhibit 5 [sic]. 

II. Clearing Agency’s Statement of the 

Purpose of, and Statutory Basis for, the 

Proposed Rule Change 

In its filing with the Commission, 

LCH SA included statements concerning 

the purpose of and basis for the 

proposed rule change and discussed any 

comments it received on the proposed 

rule change. The text of these statements 

may be examined at the places specified 

in Item IV below. LCH SA has prepared 

summaries, set forth in sections A, B, 

and C below, of the most significant 

aspects of these statements. 

A. Clearing Agency’s Statement of the 

Purpose of, and Statutory Basis for, the 

Proposed Rule Change 

1. Purpose 

The purpose of the proposed fee 

changes is for LCH SA CDSClear to 

revise the (i) fees under the Unlimited 

Tariff for General Members,5 (ii) fees for 

Corporates and Financials Index and 

Single Name CDS under the 

Introductory Tariff for both General and 

Select Members, (iii) fees set up for the 

Options clearing service for both 

General and Select Members and Clients 

as well and introduce (iv) new fee 

conditions for Affiliates clearing as 

client. 

LCH SA is currently applying the 

below fee grid for CDSClear members: 

CURRENT SELF-CLEARING TARIFF FOR CORPORATES AND FINANCIALS INDEX AND SINGLE NAME CDS 

Membership Annual fixed fee 

Self-clearing/variable fees 

EUR 

indices 

EUR 

single names 

USD 

indices 

USD 

single names 

General Member—Unlimited 

Tariff.

Ö 1,300,000 ................................. No Variable Fee Covers all self-clearing Corporate 

and Financials Index and Single Name activity for a Clearing Member and its affiliates. 

General Member—Introductory Tariff.Ö200,000 if the total annual 

gross notional cleared is under 

Ö15 billion.

Ö3.5 Per million 

gross notional 

cleared.

Ö10 Per million 

gross notional 

cleared.

$4.5 Per million 

gross notional 

cleared.

$13 Per million 

gross notional 

cleared.

Cap on total annual self-clearing 

fees (fixed + variable) of EUR 

1,300,000 after which all further trades cleared in the calendar year are subject to a fee 

holiday. 

Ö400,000 if the total annual 

gross notional cleared is over 

Ö15 billion.

Ö3.5 Per million 

gross notional 

cleared.

Ö10 Per million 

gross notional 

cleared.

$4.5 Per million 

gross notional 

cleared.

$13 Per million 

gross notional 

cleared.

Select Member .. Ö250,000 if the total annual 

gross notional cleared is under 

Ö25 billion.

Ö4 Per million 

gross notional 

cleared.

Ö10 Per million 

gross notional 

cleared.

$5 Per million 

gross notional 

cleared.

$13 Per million 

gross notional 

cleared.

Ö450,000 if the total annual 

gross notional cleared is over 

Ö25 billion.


khammond on DSKJM1Z7X2PROD with NOTICES